NCT03161405View on ClinicalTrials.gov

A Study to Evaluate the Effect of the Potent CYP3A4 Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-906 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 5, 2017

Primary Completion Date

July 2, 2017

Study Completion Date

July 10, 2017

Conditions
Healthy Participants
Interventions
DRUG

TAK-906 Maleate

TAK-906 capsule

DRUG

Itraconazole

Itraconazole solution

Trial Locations (1)

66219

Takeda Investigational Site, Lenexa

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY